Skip to main content

Measurement of cardiovascular risk factors before NHS Health Checks


Cardiovascular disease (CVD) remains the leading cause of death in the UK. Reducing the burden of CVD requires both primary and secondary prevention strategies. While there have been some primary prevention strategies in the UK over the past decade, there has been far greater focus on secondary prevention strategies targeting high risk individuals. The National Health Service (NHS) Health Check, a national primary prevention programme for vascular disease, aims to improve the prevention and early diagnosis of CVD.

In an article published recently in the medical journal JRSM Short Reports, Macide Artac and Colleagues from the Department of Primary Care & Public Health at Imperial College London  assessed measurement and level of CVD risk factors (blood pressure, cholesterol, body mass index (BMI), blood glucose and smoking status) before implementation of NHS Health Checks in general practices in the London Borough of Hammersmith & Fulham.

They found a high rate of recording of smoking status (86%) and blood pressure (83%); whilst BMI, cholesterol and glucose recording was lower. There was a large variation in BMI, cholesterol, glucose recording between general practices (e.g. 30–92% for BMI). Women had significantly better risk factor recording than men and all risk factors were better recorded in the least deprived patient group . Age-adjusted levels of cholesterol and BMI were not significantly different between men and women. Men were more likely than women to have raised blood glucose, blood pressure and BMI.

Macide Artac and colleagues concluded that before the start of the NHS Health Check programme, CVD risk factor recording varied considerably by practice and patient characteristics. They also identified significantly elevated levels of CVD risk factors in the population eligible for a Health Check, which will require considerable work to manage well.


The figure shows the general practice level variation in recording of cardiovascular disease risk factors within last 5 years.

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.